Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections.
Atea Pharmaceuticals stock last closed at $2.99, down 1.64% from the previous day, and has decreased 27.78% in one year. It has overperformed other stocks in the Biotechnology industry by 0.07 percentage points. Atea Pharmaceuticals stock is currently +8.73% from its 52-week low of $2.75, and -35% from its 52-week high of $4.60.
At the moment, there are 84.46M shares of AVIR outstanding. The market cap of AVIR is $252.54M. In the last 24 hours, 432,083 AVIR shares were traded.
How to Buy Atea Pharmaceuticals Stock
Not sure how to invest in Atea Pharmaceuticals stock? Here's how.
Choose where to buy Atea Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Atea Pharmaceuticals stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Fund your brokerage account: Choose your payment method and add your info.
Research Atea Pharmaceuticals stock: The Atea Pharmaceuticals ticker symbol is AVIR. Is Atea Pharmaceuticals stock a good investment? Should you buy shares of AVIR? How do AVIR's underlying business fundamentals look? Do top analysts think Atea Pharmaceuticals is a good buy? Why has AVIR's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if AVIR is a good stock to buy).
Execute your AVIR purchase: Decide if you will purchase AVIR shares at the current market price or use a limit order to buy AVIR shares at a specific price.
Monitor your AVIR investment: Create a watchlist to track your investment in Atea Pharmaceuticals stock.
Step 1: Choose where to buy Atea Pharmaceuticals stock
You need a brokerage account to access the NASDAQ market and buy AVIR shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Financial Services, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can buy AVIR today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Atea Pharmaceuticals stock
After you have selected the best place to buy Atea Pharmaceuticals stock, it's very important to analyze their stock prior to buying, so you actually understand the risk as well as the upside.
Atea Pharmaceuticals shares data
AVIR Price
$2.99
1w %
0.67%
1y %
-27.78%
5y %
N/A
P/E
-1.44x
P/B
0.55x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$174.01M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$252.54M
Next Earnings
Feb 26, 2025
Next Dividend
N/A
Atea Pharmaceuticals Due Diligence Score
WallStreetZen was built to help part-time investors perform better fundamental analysis.
Last year, AVIR revenue was $0.00. In the past 3 year, AVIR's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 57.84%.
Are AVIR executives and large shareholders buying or selling the stock?
Over the last year, executives and large shareholders at AVIR have sold more shares than they have bought.
Andrea Corcoran, Chief Financial Officer Executive Vice President Legal and Secretary of AVIR, was the latest AVIR insider to sell. They sold $49,272.12 worth of AVIR stock on Jan 31, 2025.
No, Atea Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your AVIR purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are generally fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at an exact price limit, use a limit order.
Click the Open Trade button and your broker will place your order.
If you want more info about investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Atea Pharmaceuticals share?
As of Feb 11, 2025, it costs $2.99 to buy one share of Atea Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.334 shares of AVIR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.